Ontvang nu dagelijks onze kooptips!

word abonnee
Van beleggers
voor beleggers
Uitgebreid zoeken

Beurscodes, betekenis en hulp bij zoeken

Europa

AEX
Euronext Amsterdam
BRU
Euronext Brussels
PSE
Euronext Paris
LIS
Euronext Lissabon
CHX
CBOE Europe, grote(re) EU aandelen
NAV
Investment Funds (NAV)

Noord-Amerika

NYS
New York Stock Exchange
OTC
CBOE BZX Exchange (US)
TSE
Toronto Stock Exchange

Kunt u een instrument niet vinden?

Zoek dan via de zogenaamde ISIN code. Elk instrument, aandeel etc. heeft een unieke code.

Kies vervolgens - wanneer er meerdere resultaten zijn - de notering op de beurs van uw keuze.

Waar vind ik die ISIN code?

Google de naam van het instrument, aandeel etc. met de toevoeging 'ISIN'.

Als zoeken op ISIN code geen resultaten oplevert hebben wij het instrument of aandeel niet in onze koersendatabase.

desktop iconMarkt Monitor
  • Word abonnee

  • Inloggen

    • Geen account? Registreren

    Wachtwoord vergeten?
Markt vandaag Koersen Forum Premium IEX Expert
Home  /  Forum  /  Amerikaanse aandelen  /  CBMG Cellular Biomedicice Group

Amerikaanse aandelen« Terug naar discussie overzicht

CBMG Cellular Biomedicice Group

Volgen
9 Posts
| Omlaag ↓
  6. forum rang 10 DeZwarteRidder 8 april 2015 21:26
    PM heeft een grote voorkeur voor frauduleuze aandelen; ANFI, NQ, GTAT en nu CBMG:
    ===========================================================================
    Cellular Biomedicine: Strong Sell On CAR-T Failure, Dishonesty Allegations And Stock Promotion, -94.6% Downside
    Apr. 7, 2015 11:53 AM ET |

    Summary

    With paid stock promotion CBMG has achieved an unsustainable $500m valuation, and with $20m in stock sold and insiders stock registered to sell, I expect CBMG will continue to collapse.
    CBMG "Car-T" technology was acquired for $1.8m, has experienced patient deaths and is worthless. CBMG recent R&D of just $4.9m makes the $500m valuation clearly absurd.
    CBMG founders face dishonesty allegations, are responsible for alleged illegal offshore stem cell clinic, while partnered with John Mattera who is currently serving 11 years in prison for fraud (again).
    Multiple accounting and financial integrity issues, CFO and Auditor turnover, "material weaknesses" and "inability to timely file" a full 50% of quarterly SEC filings raises accounting and financial integrity questions.
    Assuming CBMG is "real" and generously valuing CBMG on fundamentals show -94.6% near term and imminent downside.

    I believe Cellular Biomedicine (NASDAQ:CBMG) is another worthless Chinese reverse merger using paid stock promotion. Detailed research proves CBMG has imminent -87% to -94.6% near-term downside.
  7. [verwijderd] 8 april 2015 21:38
    quote:

    DeZwarteRidder schreef op 8 april 2015 21:26:

    PM heeft een grote voorkeur voor frauduleuze aandelen; ANFI, NQ, GTAT en nu CBMG:
    ===========================================================================
    Cellular Biomedicine: Strong Sell On CAR-T Failure, Dishonesty Allegations And Stock Promotion, -94.6% Downside
    Apr. 7, 2015 11:53 AM ET |

    Summary

    With paid stock promotion CBMG has achieved an unsustainable $500m valuation, and with $20m in stock sold and insiders stock registered to sell, I expect CBMG will continue to collapse.
    CBMG "Car-T" technology was acquired for $1.8m, has experienced patient deaths and is worthless. CBMG recent R&D of just $4.9m makes the $500m valuation clearly absurd.
    CBMG founders face dishonesty allegations, are responsible for alleged illegal offshore stem cell clinic, while partnered with John Mattera who is currently serving 11 years in prison for fraud (again).
    Multiple accounting and financial integrity issues, CFO and Auditor turnover, "material weaknesses" and "inability to timely file" a full 50% of quarterly SEC filings raises accounting and financial integrity questions.
    Assuming CBMG is "real" and generously valuing CBMG on fundamentals show -94.6% near term and imminent downside.

    I believe Cellular Biomedicine (NASDAQ:CBMG) is another worthless Chinese reverse merger using paid stock promotion. Detailed research proves CBMG has imminent -87% to -94.6% near-term downside.
    gefrustreerd over SBM ZR? Ze gaan nog veel lager verwacht ik:-) Naar minimaal 9 Euris :-))
9 Posts
|Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met je emailadres en wachtwoord.

Direct naar Forum

Markt Vandaag

Stijgers

instrument koers absoluut verschil relatief verschil
Sif Holding 14,320 +1,14 +8,65%
TomTom 5,315 +0,37 +7,46%
AALBERTS NV 36,180 +2,18 +6,41%
ADYEN NV 1.396,200 +74,20 +5,61%
ASMI 591,200 +31,20 +5,57%
FASTNED 18,960 +0,98 +5,45%
HEIJMANS KON 24,650 +1,15 +4,89%
PROSUS 34,065 +1,54 +4,73%
ASML 747,900 +32,90 +4,60%
BESI 116,950 +4,80 +4,28%
ArcelorMittal 21,900 +0,80 +3,79%
AMG Critical Materials N.V. 16,620 +0,55 +3,42%
Air France-KLM 8,892 +0,29 +3,37%
Fugro 21,140 +0,64 +3,12%
Aegon 5,634 +0,17 +3,11%
ALLFUNDS GROUP 5,505 +0,17 +3,09%
Akzo Nobel 60,020 +1,52 +2,60%
Van Lanschot Kempen NV 42,650 +1,05 +2,52%
ASR Nederland 43,800 +1,03 +2,41%
Arcadis 64,050 +1,50 +2,40%
Aperam 24,800 +0,58 +2,39%
TKH 37,940 +0,88 +2,37%
Alfen N.V. 12,955 +0,30 +2,33%
BAM 3,812 +0,09 +2,31%
RANDSTAD NV 44,610 +0,99 +2,27%
JUST EAT TAKEAWAY 12,905 +0,28 +2,22%
SBM Offshore 16,510 +0,33 +2,04%
ACOMO 17,560 +0,34 +1,97%
ASCX 1.213,37 +21,41 +1,80%
AMX 901,24 +15,68 +1,77%
AEX 908,42 +15,79 +1,77%
SHELL PLC 31,180 +0,53 +1,73%
NN Group 44,960 +0,72 +1,63%
CM.COM 6,570 +0,10 +1,55%
AZERION 1,580 +0,02 +1,54%
Kendrion 12,260 +0,18 +1,49%
EXOR NV 99,300 +1,45 +1,48%
Basic-Fit 22,660 +0,32 +1,43%
SIGNIFY NV 21,380 +0,30 +1,42%
OCI 26,700 +0,37 +1,41%
WDP 24,400 +0,30 +1,24%
CTP 16,460 +0,20 +1,23%
ING 16,682 +0,20 +1,20%
ForFarmers 3,180 +0,04 +1,11%
JDE PEET'S 20,060 +0,22 +1,11%
IMCD 155,400 +1,65 +1,07%
RELX 43,100 +0,44 +1,03%
NSI 20,900 +0,20 +0,97%
B&S Group SA 4,740 +0,04 +0,96%
NX FILTRATION 4,500 +0,04 +0,90%
UMG 23,070 +0,20 +0,87%
Heineken 81,060 +0,66 +0,82%
PostNL 1,232 +0,01 +0,82%
Wolters Kluwer 156,300 +1,25 +0,81%
Flow Traders 18,270 +0,14 +0,77%
Pharming 0,707 +0,01 +0,71%
Nedap N.V. 57,200 +0,40 +0,70%
Sligro 13,200 +0,08 +0,61%
Corbion 23,820 +0,10 +0,42%
Wereldhave 14,740 +0,06 +0,41%
Eurocommercial Properties 25,300 +0,10 +0,40%
INPOST 17,420 +0,06 +0,35%
RENEWI 7,700 +0,02 +0,26%
Philips Koninklijke 27,810 +0,07 +0,25%
Brunel 8,800 +0,02 +0,23%
Vastned 23,800 0,00 0,00%

Dalers

instrument koers absoluut verschil relatief verschil
Avantium 1,880 -0,07 -3,59%
KPN 3,607 -0,08 -2,20%
Vopak 41,940 -0,72 -1,69%
Galapagos 26,920 -0,42 -1,54%
Ahold Delhaize 30,560 -0,32 -1,04%
DSM FIRMENICH AG 116,000 -1,05 -0,90%
THEON INTERNAT 10,820 -0,04 -0,37%
Accsys 0,630 0,00 -0,32%
UNILEVER PLC 57,760 -0,16 -0,28%
ABN AMRO BANK N.V. 16,250 -0,04 -0,25%
EBUSCO HOLDING 0,795 0,00 -0,13%
Fagron 18,780 -0,02 -0,11%
vlag naam koers verschil relatief verschil
AEX 908,42 +15,79 +1,77%
AEX GR 3.549,84 +61,68 +1,77%
Germany40^ 18.974,00 +262,51 +1,40%
FTSE 100 8.328,72 +75,04 +0,91%
EURO50 4.939,39 +94,16 +1,94%
US30^ 42.038,60 +528,20 +1,27%
Nasd100^ 19.844,80 +496,50 +2,57%
US500^ 5.713,11 +93,81 +1,67%
Japan225^ 37.767,50 +1.136,60 +3,10%
VD-NEW 14,20 -1,21 -7,84%
#/^ Index indications calculated real time, zie disclaimer